NCT03498820View on ClinicalTrials.gov

Analgesia-Nociception Index Guided Intraoperative Remifentanil Administration Versus Standard Practice:Evaluation of Perioperative Opioid Use

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 19, 2018

Primary Completion Date

December 19, 2019

Study Completion Date

March 13, 2020

Conditions
PainAnesthesia
Interventions
DEVICE

Analgesia Nociception Index

: Non invasive monitor based on heart rate variability analysis, assessing the parasympathetic nervous activity

DRUG

Remifentanil

intravenous short-acting opioid routinely administered during general anesthesia

Trial Locations (1)

75012

Service d'Anesthésie-réanimation chirurgicale - Hôpital Trousseau, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03498820 - Analgesia-Nociception Index Guided Intraoperative Remifentanil Administration Versus Standard Practice:Evaluation of Perioperative Opioid Use | Biotech Hunter | Biotech Hunter